Replies to post #10362 on Avid Bioservices Inc (CDMO)

[jakedogman1]

Very frustrated with PPHM mgmt on one aspect. IMO, they are not doing their job in having stock price match the potential of the company. Lytle admitted this on one of the recent CC's. I also believe they don't care about price because the lower the price is, the more mgmt benefits when they are awarded options based on milestone awards. I would like to see the criteria for the awards and have stock price as compared to previous quarters be part of the criteria. One can say a small cap is easy to push around. IMO, they are not getting the story out or they are not good at telling it (or they don't want it to be told until they get their options). It would not take that many institutional players to maintain the price. Mgmt needs to be held accountable for the poor performance.

[volgoat]

the answer is yes, the pphm deal was much better.......

[westjtter]

I agree that PPHM has been able to secure much better financing deals ala ES(for those of you still doubting him, ES is a brilliant tactician when it comes to financing). Ironically, I also own a wack of MCU, and was disappointed in their latest financing. Another case of a well run company with excellant potential for their drug platforms having to go to the sharks for financing. Bert Friesen the CEO, is also prepared to go it alone if necessary as they were also negotiating with a partner who obviously wanted too much. A partner would have spiked the share price much quicker, but it probably makes sense to go it alone for a time longer to build additional shareholder value.......SOUNDS FAMILIAR DOESN'T IT!

As much as I like Medicure(MCU), I feel PPHM has much greater potential, and we should start seeing something in the next 30 days.